Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Medical Health Screening Market Revenue Outlook: What CAGR Is Expected Through 2030?

The medical health screening market size has exhibited strong growth in recent years. It is anticipated to expand from $19.74 billion in 2025 to $21.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. The market’s historic expansion can be linked to factors such as increased public understanding of preventive healthcare, the expansion of diagnostic laboratory networks, a growing incidence of chronic diseases, better access to standard testing services, and the development of health programs sponsored by employers.

The medical health screening market size is projected to experience substantial expansion over the upcoming years. By 2030, it is anticipated to reach $26.97 billion, demonstrating a compound annual growth rate (CAGR) of 6.4%. This anticipated growth during the forecast period stems from factors such as the increasing embrace of personalized medicine methods, greater incorporation of digital health platforms, broader implementation of population-level screening programs, a rise in demand for home-based testing offerings, and a heightened emphasis on the early detection of cancer. Key developments anticipated during this period encompass the wider adoption of preventive health screening initiatives, an increase in the utilization of multi-parameter diagnostic panels, a growing need for early disease detection services, the expansion of corporate and occupational health screening, and a stronger focus on individualized screening protocols.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25824&type=smp

Medical Health Screening Market Opportunity Drivers: What Is Creating New Revenue Potential?

The increasing occurrence of chronic illnesses is anticipated to boost the expansion of the medical health screening market in the future. These long-term health issues, exemplified by diabetes, heart disease, and asthma, typically last for at least a year, necessitating ongoing medical attention or restricting daily activities. Sedentary habits contribute to the growing frequency of chronic diseases, given that extended periods of inactivity diminish general health and heighten susceptibility to such conditions. Medical health screening offers significant benefits for chronic diseases by facilitating the early detection of risk factors and signs. This early identification enables prompt action and treatment, which helps prevent complications, enhances the quality of life, and lessens the total impact of these enduring health problems. As an illustration, in April 2025, the International Diabetes Federation, a Belgium-based non-profit organization, reported that 589 million adults aged 20–79 currently live with diabetes globally, with projections indicating an increase to 853 million by 2050. Consequently, the increasing prevalence of chronic diseases is a key factor propelling the expansion of the medical health screening market.

Medical Health Screening Market Segment Analysis Highlighting Growth Areas

The medical health screening market covered in this report is segmented –

1) By Test Type: Routine Tests, Non-Routine Tests, Cancer Screening Tests, Specialty Tests, Other Test Types

2) By Sample Type: Blood, Urine, Saliva, Other Sample Types

3) By End User: Hospitals Or Clinics, Diagnostic Laboratories, Workplaces, Research Institutes, Other End Users

Subsegments:

1) By Routine Tests: Blood Pressure Monitoring, Blood Glucose Testing, Lipid Profile, Complete Blood Count (CBC), Urinalysis

2) By Non-Routine Tests: Genetic Testing, Hormonal Testing, Allergy Testing, Infectious Disease Testing

3) By Cancer Screening Tests: Mammography, Pap Smear Test, Colonoscopy, Prostate-Specific Antigen (PSA) Test, Low-Dose CT Scan For Lung Cancer

4) By Specialty Tests: Cardiovascular Screening, Neurological Screening, Pulmonary Function Tests, Bone Density Test

5) By Other Test Types: Wellness Tests, Executive Health Checkups, Prenatal Screening, Occupational Health Screening

Medical Health Screening Market Innovation Trends Driving Future Development

Leading companies active in the medical health screening market are concentrating on introducing innovative solutions, such as artificial intelligence-powered radiology informatics and cancer screening, to enhance early detection, improve diagnostic accuracy, and streamline clinical workflows. AI-powered radiology informatics and cancer screening involve utilizing artificial intelligence technologies to analyze medical imaging data and identify potential signs of cancer or other abnormalities with increased speed and accuracy. For example, in February 2025, DeepHealth, a US-based health informatics company, launched a new suite of AI-powered radiology informatics and cancer screening solutions, powered by their cloud-native operating system, DeepHealth OS. This suite includes the Diagnostic Suite, a unified AI-driven diagnostic workspace, and advanced AI tools for lung, prostate, and brain health screening. These innovations aim to enhance clinical accuracy, streamline workflows, and improve operational efficiency across diverse healthcare settings.

Medical Health Screening Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the medical health screening market are Abbott Laboratories, Siemens Healthineers AG, Labcorp Holdings Inc, Quest Diagnostics Incorporated, Eurofins Scientific SE, QuidelOrtho Corporation, Exact Sciences Corporation, Unilabs AB, LifeLabs LP, ARUP Laboratories, BioReference Health LLC, Guardant Health Inc, DDRC Agilus Diagnostics Limited, Clinical Reference Laboratory Inc, Freenome Holdings Inc, Genova Diagnostics Inc, Cerba Healthcare SAS, DELFI Diagnostics Inc, Truvian Sciences Inc, ACM Medical Laboratory Inc, LabPlus, Sonic Healthcare Limited

Access The Complete Medical Health Screening Market Report:

https://www.thebusinessresearchcompany.com/report/medical-health-screening-global-market-report

Medical Health Screening Market Geographic Distribution And Regional Opportunities

North Americawas the largest region in the medical health screening market in 2025. The regions covered in the medical health screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model